Watson International Ltd.China Business Department

Supplier Manufacturer, Distributor,
China


Watson International Ltd is a research and development focused company for fine chemicals.


Products and services
Chemical Substances, Coating materials
Product Categories
API Intermediates
Products
Expand All | Collapse All
Showing 1871 to 1880 of 7522 Suppliers first | previous | next | last

2H-1,4-Benzoxazin-3(4H)-one, 7-hydroxy- (1 variant)

CAS Number: 67193-97-9 | Intermediates

2H-1,4-Benzoxazin-8-ol,3,4-dihydro-(9CI) (1 variant)

CAS Number: 704879-73-2 | Intermediates

2H-1,4-Benzoxazine, 4-acetyl-7-bromo-3,4-dihydro- (1 variant)

CAS Number: 280142-79-2 | Intermediates

2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-[(1E)-4-(3-chlorophenoxy)-3-oxo-1-buten-1-yl]hexahydro-, (3aR,4R,5R,6aS)- (1 variant)

CAS Number: 178454-81-4 | Intermediates

2H-Cyclopenta[b]furan-2-one, 4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-5-hydroxy-, (3aR,4R,5R,6aS)- (1 variant)

CAS Number: 209861-01-8 | Intermediates

2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-[(1E,3S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-octen-1-yl]hexahydro-, (3aR,4R,5R,6aS)- (1 variant)

CAS Number: 587869-81-6 | Intermediates

2H-Cyclopenta[b]furan-2-one, hexahydro-4-(hydroxymethyl)-5-[(triethylsilyl)oxy]-, (3aR,4S,5R,6aS) (1 variant)

CAS Number: 913258-07-8 | Intermediates

2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-(hydroxymethyl)- (1 variant)

CAS Number: 521323-11-5 | Intermediates

2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-, (3aR,4R,5R,6aS)- (1 variant)

CAS Number: 26054-67-1 | Intermediates

2H-Cyclopenta[b]furan-2-one,hexahydro-4-[(1E,3S,5S)-5-methyl-3-[(tetrahydro-2H-pyran-2-yl)oxy]-1-nonen-1-yl]-5-[(tetrahydro-2H-pyran-2-yl)oxy]-, (3aR,4R,5R,6aS)- (1 variant)

CAS Number: 101849-78-9 | Intermediates

Register NOW →

Find new trading partners and manage your transactions through every step of the Pharmaceutical supply chain from Quoting to Shipping. Whether you're a buyer or a supplier the iOPharma platform will benefit your organisation.

Close

loading...
Close

Close